Roche’s Giredestrant Shows Significant Progression-Free Survival Benefit in Phase III ER-Positive Breast Cancer Trial Read more
Eli Lilly to Build $6.5 Billion Manufacturing Facility in Houston, Boosting U.S. Drug Production Read more
Minovia Therapeutics’ MNV-201 Granted FDA Fast Track Designation for Myelodysplastic Syndrome Read more
Novo Nordisk: Ozempic Lowers Heart Attack, Stroke, and Death Risk by 23% vs. Dulaglutide in Real-World Study Read more